High serum IgA levels in patients with IgG4-related disease are associated with mild inflammation, sufficient disease-specific features, and favourable responses to treatments
© Japan College of Rheumatology 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
OBJECTIVES: Although elevated serum immunoglobulin A (IgA) levels are thought to exclude a diagnosis of IgG4-related disease (IgG4-RD), IgG4-RD has been definitively diagnosed in some patients despite elevated serum IgA levels. This study aimed to clarify the prevalence of elevated IgA levels in patients with IgG4-RD and to compare the clinical features of IgG4-RD patients with and without elevated IgA levels.
METHODS: The clinical features of 169 IgG4-RD patients were retrospectively compared among those with and without elevated serum IgA levels.
RESULTS: Of the 169 patients with IgG4-RD, 17 (10.1%) had elevated serum IgA levels. Those with elevated serum IgA levels showed higher serum C-reactive protein levels and lower prevalence of relapse than those without. Other clinical features did not differ significantly, including inclusion scores of the American College of Rheumatology/European League Against Rheumatism classification criteria. Cox regression analysis showed that elevated serum IgA levels were associated with a lower incidence of relapse. Moreover, patients with elevated serum IgA levels showed prompt improvement in response to glucocorticoids in the IgG4-RD responder index.
CONCLUSIONS: Some patients diagnosed with IgG4-RD have high serum IgA levels. These patients may form a subgroup, characterized by good response to glucocorticoids, less frequent relapse, mildly elevated serum C-reactive protein levels, and possible complications of autoimmune diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Modern rheumatology - 34(2024), 3 vom: 28. März, Seite 621-631 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tsuge, Shunsuke [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-41-4 |
---|
Anmerkungen: |
Date Completed 29.03.2024 Date Revised 11.04.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/mr/road056 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358091446 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM358091446 | ||
003 | DE-627 | ||
005 | 20240411232049.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/mr/road056 |2 doi | |
028 | 5 | 2 | |a pubmed24n1372.xml |
035 | |a (DE-627)NLM358091446 | ||
035 | |a (NLM)37307433 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tsuge, Shunsuke |e verfasserin |4 aut | |
245 | 1 | 0 | |a High serum IgA levels in patients with IgG4-related disease are associated with mild inflammation, sufficient disease-specific features, and favourable responses to treatments |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.03.2024 | ||
500 | |a Date Revised 11.04.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Japan College of Rheumatology 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a OBJECTIVES: Although elevated serum immunoglobulin A (IgA) levels are thought to exclude a diagnosis of IgG4-related disease (IgG4-RD), IgG4-RD has been definitively diagnosed in some patients despite elevated serum IgA levels. This study aimed to clarify the prevalence of elevated IgA levels in patients with IgG4-RD and to compare the clinical features of IgG4-RD patients with and without elevated IgA levels | ||
520 | |a METHODS: The clinical features of 169 IgG4-RD patients were retrospectively compared among those with and without elevated serum IgA levels | ||
520 | |a RESULTS: Of the 169 patients with IgG4-RD, 17 (10.1%) had elevated serum IgA levels. Those with elevated serum IgA levels showed higher serum C-reactive protein levels and lower prevalence of relapse than those without. Other clinical features did not differ significantly, including inclusion scores of the American College of Rheumatology/European League Against Rheumatism classification criteria. Cox regression analysis showed that elevated serum IgA levels were associated with a lower incidence of relapse. Moreover, patients with elevated serum IgA levels showed prompt improvement in response to glucocorticoids in the IgG4-RD responder index | ||
520 | |a CONCLUSIONS: Some patients diagnosed with IgG4-RD have high serum IgA levels. These patients may form a subgroup, characterized by good response to glucocorticoids, less frequent relapse, mildly elevated serum C-reactive protein levels, and possible complications of autoimmune diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a C-Reactive protein | |
650 | 4 | |a IgA | |
650 | 4 | |a IgG4-related disease | |
650 | 4 | |a relapse | |
650 | 4 | |a response | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a Immunoglobulin A |2 NLM | |
700 | 1 | |a Mizushima, Ichiro |e verfasserin |4 aut | |
700 | 1 | |a Horita, Makoto |e verfasserin |4 aut | |
700 | 1 | |a Kawahara, Hiroyuki |e verfasserin |4 aut | |
700 | 1 | |a Sanada, Hajime |e verfasserin |4 aut | |
700 | 1 | |a Yoshida, Misaki |e verfasserin |4 aut | |
700 | 1 | |a Takahashi, Yoshinori |e verfasserin |4 aut | |
700 | 1 | |a Zoshima, Takeshi |e verfasserin |4 aut | |
700 | 1 | |a Nishioka, Ryo |e verfasserin |4 aut | |
700 | 1 | |a Hara, Satoshi |e verfasserin |4 aut | |
700 | 1 | |a Suzuki, Yasunori |e verfasserin |4 aut | |
700 | 1 | |a Ito, Kiyoaki |e verfasserin |4 aut | |
700 | 1 | |a Kawano, Mitsuhiro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Modern rheumatology |d 2000 |g 34(2024), 3 vom: 28. März, Seite 621-631 |w (DE-627)NLM162086628 |x 1439-7609 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2024 |g number:3 |g day:28 |g month:03 |g pages:621-631 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/mr/road056 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2024 |e 3 |b 28 |c 03 |h 621-631 |